Roth MKM analyst Bill Kirk lowered the firm’s price target on Brown-Forman to $48 from $49 and keeps a Neutral rating on the shares. The firm warns that with Q1 depletions down 9%, the path to implied positive depletions for the full-year is not clear, while the company’s guidance requires a positive 3% growth for remainder of year, the analyst tells investors in a research note. Prior year comparisons get easier, but pricing competitiveness, inventory levels, and an uncertain consumer environment make an inflection of that magnitude difficult to rely upon, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BF.B:
- Morning Movers: Best Buy jumps and Dollar General plummets following Q2 results
- Brown-Forman sees FY25 organic net sales up 2%-4%
- Brown-Forman reports Q1 EPS 41c, consensus 46c
- Brown-Forman several quarters away from better visibility, says RBC Capital
- Brown-Forman Corp (BF-B) (BF.B) Q1 Earnings Cheat Sheet